Patient access to precision medicine: Identifying barriers to biomarker testing in non-small cell lung cancer.

被引：0
|
作者：
Levent, Ayse
De Richter, Pieter
Bender, Hope
机构：
[1] Ipsos, New York, NY USA
[2] Ipsos, Kuala Lumpur, Malaysia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3131
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer
    Sakamoto, Tomohiro
    Matsubara, Taichi
    Takahama, Takayuki
    Yokoyama, Toshihide
    Nakamura, Atsushi
    Tokito, Takaaki
    Okamoto, Tatsuro
    Akamatsu, Hiroaki
    Oki, Masahide
    Sato, Yuki
    Tobino, Kazunori
    Ikeda, Satoshi
    Mori, Masahide
    Mimura, Chihiro
    Maeno, Ken
    Miura, Satoru
    Harada, Toshiyuki
    Nishimura, Kunihiro
    Hiraoka, Manabu
    Kenmotsu, Hirotsugu
    Fujimoto, Junya
    Shimokawa, Mototsugu
    Yamamoto, Nobuyuki
    Nakagawa, Kazuhiko
    JAMA NETWORK OPEN, 2023, 6 (12) : E2347700
  • [42] Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective
    Malapelle, Umberto
    Tiseo, Marcello
    Vivancos, Ana
    Kapp, Joshua
    Jose Serrano, M.
    Tiemann, Markus
    JOURNAL OF MOLECULAR PATHOLOGY, 2021, 2 (03): : 255 - 273
  • [43] NAVIGATING ACCESS TO CANCER CARE: IDENTIFYING BARRIERS TO PRECISION CANCER MEDICINE
    Cooper, Kayla E.
    Abdallah, Khadijah E.
    Angove, Rebekah S. M.
    Gallagher, Kathleen D.
    Bonham, Vence L.
    ETHNICITY & DISEASE, 2022, 32 (01) : 39 - 48
  • [44] Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service
    Karunanithi, Vijayalakshmi
    Win, Thida
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [45] Molecular testing in non-small cell lung cancer
    Mahmood, Bayan
    Yin, Su Lei
    Muhammad, SyedAun
    Dancey, Gairin
    Medeiros, Filomena
    LUNG CANCER, 2022, 165 : S35 - S35
  • [46] Collagen XXIII: A biomarker for non-small cell lung cancer
    Spivey, Kristin A.
    Banyard, Jacqueline
    Solis, Luisa M.
    Wistuba, Ignacio I.
    Barletta, Justine A.
    Gandhi, Leena
    Feldman, Henry A.
    Rodig, Scott J.
    Chirieac, Lucian R.
    Zetter, Bruce R.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [47] BIOMARKER FOR BRAIN METASTASIS OF NON-SMALL CELL LUNG CANCER
    Yang, Seung-Ho
    Yoo, Jin Young
    Cho, Deog Gon
    Kim, Hoo Kyo
    Kim, Sung Whan
    Lee, Sang Won
    NEURO-ONCOLOGY, 2010, 12 : 64 - 64
  • [48] Osteopontin is a prognostic biomarker in non-small cell lung cancer
    Rud, Ane Kongsgaard
    Boye, Kjetil
    Oijordsbakken, Miriam
    Lund-Iversen, Marius
    Halvorsen, Ann Rita
    Solberg, Steinar K.
    Berge, Gisle
    Helland, Aslaug
    Brustugun, Odd Terje
    Maelandsmo, Gunhild M.
    BMC CANCER, 2013, 13
  • [49] Barriers to non-small cell lung cancer trial eligibility
    Hardesty, Jeffrey J.
    Kanarek, Norma F.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2018, 9 : 45 - 49
  • [50] Precision Management of Advanced Non-Small Cell Lung Cancer
    Yang, Ching-Yao
    Yang, James Chih-Hsin
    Yang, Pan-Chyr
    ANNUAL REVIEW OF MEDICINE, VOL 71, 2020, 2020, 71 : 117 - 136
12345